Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell LymphomaFrederick L. Locke,David B. Miklos,Caron Jacobson,Miguel-Angel Perales,Marie Jose Kersten,Olalekan O. Oluwole,Armin Ghobadi,Aaron P. Rapoport,Joseph P. McGuirk,John M. Pagel,Javier Munoz,Umar Farooq, Tom Van Meerten,Patrick M. Reagan,Anna Sureda,Ian W. Flinn,Peter Vandenberghe,Kevin Song,Michael Dickinson,Monique C. Minnema,Peter A. Riedell, Lori A. Leslie, Sridhar Chaganti,Yin Yang,Simone Filosto,Marco Schupp,Christina To,Paul Cheng,Leo I. Gordon,Jason R. WestinBLOOD（2021）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
